Is Schwab U.S. Dividend Equity ETF Becoming a Crowded Trade That Smart Investors Should Avoid?
The Motley Fool· 2026-03-28 03:15
From a big-picture perspective, Schwab U.S. Dividend Equity ETF (SCHD 0.59%) is a thematic investment focused on dividend-paying stocks. That, however, is very different from, say, a sector-focused exchange-traded fund. And it changes the equation when you consider the popularity of Schwab U.S. Dividend Equity ETF, which manages a huge $85 billion of assets.What does Schwab U.S. Dividend Equity ETF do?Schwab U.S. Dividend Equity ETF does not follow a specific sector or invest in a specific niche (such as ar ...
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Coty Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - COTY
TMX Newsfile· 2026-03-28 03:14
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Coty Inc. (NYSE: COTY) between November 5, 2025 and February 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 22, 2026.SO WHAT: If you purchased Coty common stock during the Class Period you may be enti ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - CORT
TMX Newsfile· 2026-03-28 03:10
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you purchased Corcept common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a continge ...
Company Notes Series (#14): The Central and Eastern Europe Fund : The Good Investors %
The Good Investors· 2026-03-28 03:08
Editor’s note: This is the latest edition in the “Company Notes Series”, where we periodically share our notes on companies we’ve studied in the recent past but currently have no vested interest in (we may invest in or sell shares in the companies mentioned at any time). The notes are raw and not updated, and the “as of” date for the data is given at the start of the notes. The first 13 editions in the series can be found here, here, here, here, here, here, here, here, here, here, here, here, and here. P ...
James Turk Broadcast Interview – Available Now
Kingworldnews· 2026-03-28 03:06
James Turk Broadcast Interview – Available Now FOR DIRECTIONS ON HOW TO PLAY OR DOWNLOAD AUDIOS: CLICK HEREJames Turk: Founder & Lead Director of Goldmoney, Inc (Toronto Exchange XAU) – In his latest book, MONEY AND LIBERTY, James Turk explains the inextricable link between liberty and politically honest money that only gold can provide. Drawing upon five decadesof experience in international finance, he explains why national currencies and banking today are based on outdated ideas that have become harmful ...
Adidas Stock: Buy At Undemanding Valuations As Inventory Set To Normalize (OTCMKTS:ADDYY)
Seeking Alpha· 2026-03-28 03:05
Adidas ( ADDYY) ( ADDDF ) has been able to deliver a strong recovery to its top line over the past year, but the quality of that growth remains a point of debate, which has definitelyEquity Research Analyst at DM Martins Research.I cover stocks that are often undercovered, focusing primarily on Brazil and Latin America — but I also occasionally write about global large caps. My work can also be found on TipRanks, where I contribute regularly, and on TheStreet, where I was a frequent contributor in the past. ...
PAYSAFE DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Paysafe Limited Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action - PSFE
TMX Newsfile· 2026-03-28 03:02
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.WHAT TO ...
POMDOCTOR DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
Globenewswire· 2026-03-28 03:01
NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline. SO WHAT: If you purchased PomDoctor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...
Is Celsius Stock a Buy After Falling 49% From Its 52-Week High?
The Motley Fool· 2026-03-28 03:01
Shares of energy drink maker Celsius Holdings (CELH 4.64%) have taken a severe hit recently. Down a staggering 49% from its 52-week high of $66.74, the stock is currently trading at about $34 per share as of this writing. Much of the recent pressure on the stock stems from news that wholesale giant Costco recently launched a private-label Kirkland Signature energy drink. The new product is priced significantly lower than Celsius, sparking fears of intensifying competition and prompting a sharp sell-off in t ...
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
TMX Newsfile· 2026-03-28 03:01
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline.SO WHAT: If you purchased Boston Scientific common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency ...